- Home
- SLF vs PTCT Comparison
SLF vs PTCT Comparison
Compare SLF & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLF | PTCT |
|---|---|---|
| Founded | 1871 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.1B | 6.1B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | SLF | PTCT |
|---|---|---|
| Price | $68.63 | $69.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 18 |
| Target Price | ★ $84.00 | $76.28 |
| AVG Volume (30 Days) | 511.0K | ★ 1.0M |
| Earning Date | 02-11-2026 | 02-19-2026 |
| Dividend Yield | ★ 3.66% | N/A |
| EPS Growth | ★ 17.05 | N/A |
| EPS | 4.49 | ★ 8.94 |
| Revenue | ★ $25,438,327,787.00 | $1,779,150,000.00 |
| Revenue This Year | N/A | $132.16 |
| Revenue Next Year | $5.56 | N/A |
| P/E Ratio | $15.32 | ★ $7.91 |
| Revenue Growth | 5.37 | ★ 97.54 |
| 52 Week Low | $52.44 | $35.95 |
| 52 Week High | $68.94 | $87.50 |
Technical Indicators
Market Signals| Indicator | SLF | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 73.80 | 37.18 |
| Support Level | $64.29 | $69.75 |
| Resistance Level | $65.67 | $76.99 |
| Average True Range (ATR) | 1.15 | 2.60 |
| MACD | 0.43 | -0.44 |
| Stochastic Oscillator | 89.34 | 13.85 |
Price Performance
Historical ComparisonAbout SLF Sun Life Financial Inc.
Sun Life Financial is one of the Big Three Canadian life insurers. The Canadian business contributed around 38% of adjusted earnings. In that segment, the firm provides health, life insurance, and annuity products to individual and group customers. Its US business is mostly group health and contributed about 20% of the firm's adjusted earnings in 2024. Sun Life also offers life insurance and wealth products in several Asian markets with a strong presence in Hong Kong and the Philippines. The Asia segment contributed around 18% of adjusted 2024 earnings. Its asset management business had around CAD 1.1 trillion total assets under management or administration at the end of 2024 and represents around 34% of the firm's earnings.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.